SCHEMBL14832259

SCHEMBL14832259

ClC1(c2ccc3c(c2)COCc2nncn2-3)CCC(Oc2cnccn2)CC1

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.33
NAAA Q02083 1/20 0.31
AVPR1A P37288 3/20 0.31
AVPR2 P30518 1/20 0.31
KCNH2 Q12809 1/20 0.31
EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14832404 0.89 AVPR1A (0.41) AVPR1AAVPR2KCNH2
SCHEMBL2472708 0.86 CYP11B2 (0.33) CYP11B2NAAAEPHX2
SCHEMBL2473757 0.79 GPR119 (0.34) AVPR1AEPHX2
SCHEMBL14844442 0.76 AVPR1A (0.35) CYP11B2AVPR1A
SCHEMBL14844175 0.75
SCHEMBL2474933 0.75 AVPR1A (0.39) AVPR1AAVPR2KCNH2
SCHEMBL14844410 0.75
SCHEMBL2471774 0.74 CYP11B2 (0.30) CYP11B2
Hydrochloric Acid SCHEMBL2472336 0.73
SCHEMBL14844475 0.73 AVPR1A (0.42) AVPR1AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760871-A1 OXY-CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES AS V1A ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2014-08-06 EP claimed
WO-2013045373-A1 OXY-CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES AS V1A ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2013-04-04 WO claimed
EP-2760871-A1 OXY-CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES AS V1A ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2014-08-06 EP disclosed
WO-2013045373-A1 OXY-CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES AS V1A ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2013-04-04 WO disclosed